Abstract

Transcranial Doppler (TCD) monitoring of the intracranial vessels is useful for the detection of microembolic signals (MES), which can help with risk stratification and evaluation of therapies. The presence of any emboli during a TCD exam is concerning and treatment is controversial. In this case, an unusual high count of emboli were detected in all vessels, which prompted a change in clinical management. It is now believed that the injectable cardiovascular ultrasound contrast agent (Definity®) was the cause of the large number of MES. Ramanathan reported a similar case in which an unusual amount of MES were detected during emboli monitoring (EM) and were felt to be contamination from Definity® contrast injected 2 hours prior to the EM exam. When unexpectedly faced with numerous MES, practitioners should consider other factors that can influence the results of TCD with EM.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.